Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature

Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):142-148. doi: 10.1016/j.pcad.2020.02.006. Epub 2020 Feb 11.


Despite developments to improve health in the United States, racial and ethnic disparities persist. These disparities have profound impact on the wellbeing of historically marginalized racial and ethnic groups. This narrative review explores disparities by race in people living with cardiovascular disease (CVD) and the Human Immunodeficiency Virus (HIV). We discuss selected common social determinants of health for both of these conditions which include; regional historical policies, incarceration, and neighborhood effects. Data on racial disparities for persons living with comorbid HIV and CVD are lacking. We found few published articles (n = 7) describing racial disparities for persons living with both comorbid HIV and CVD. Efforts to reduce CVD morbidity in historically marginalized racial and ethnic groups with HIV must address participation in clinical research, social determinants of health and translation of research into clinical practice.

Keywords: Cardiovascular disease; HIV; Historically marginalized racial and ethnic groups; People living with HIV; Racial disparities.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / ethnology
  • Cardiovascular Diseases / prevention & control*
  • Comorbidity
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Infections / ethnology
  • HIV Long-Term Survivors*
  • Health Status Disparities*
  • Healthcare Disparities / ethnology*
  • Humans
  • Preventive Health Services*
  • Prognosis
  • Protective Factors
  • Race Factors
  • Risk Assessment
  • Risk Factors
  • Social Determinants of Health
  • Social Marginalization*
  • Socioeconomic Factors
  • Viral Load
  • Vulnerable Populations*


  • Anti-HIV Agents